Analyst Ratings for Dianthus Therapeutics (DNTH)
DNTH Rating Summary
DNTH Price Target Summary
- Highest: $200.00 (Guggenheim)
- Lowest: $98.00 (Wolfe Research)
- Average: $136.15
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$136.15 (+88.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$136.15 (+88.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/11/2026 | JPMorgan | Brian Cheng | New Coverage | Overweight (N/A) |
135.00 (N/A) |
107.04 (72.09) |
-32.65% | Details |
| 9/4/2026 | Citi | Samantha Semenkow | New Coverage | Buy (N/A) |
156.00 (N/A) |
107.85 (72.09) |
-33.16% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
